ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 127 filers reported holding ARCELLX INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,184,142 | +16.0% | 367,451 | +2.2% | 0.00% | +50.0% |
| Q2 2023 | $11,368,971 | +38.6% | 359,550 | +35.1% | 0.00% | 0.0% |
| Q1 2023 | $8,200,513 | -4.4% | 266,164 | -3.9% | 0.00% | 0.0% |
| Q4 2022 | $8,580,778 | +79.0% | 276,978 | +8.5% | 0.00% | +100.0% |
| Q3 2022 | $4,793,000 | +174.0% | 255,356 | +164.0% | 0.00% | – |
| Q2 2022 | $1,749,000 | +44.9% | 96,724 | +12.3% | 0.00% | – |
| Q1 2022 | $1,207,000 | – | 86,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 3,946,630 | $141,605,084 | 72.57% |
| NEA Management Company, LLC | 3,745,262 | $134,380,001 | 10.38% |
| Paradigm Biocapital Advisors LP | 2,953,122 | $105,958,017 | 7.19% |
| Samsara BioCapital, LLC | 613,921 | $22,027,485 | 6.74% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,869,967 | $102,974,416 | 5.56% |
| Perceptive Advisors | 3,965,978 | $142,299,291 | 4.75% |
| Cormorant Asset Management, LP | 2,150,000 | $77,142,000 | 4.50% |
| Affinity Asset Advisors, LLC | 400,000 | $14,352,000 | 4.04% |
| Novo Holdings A/S | 1,075,000 | $38,571,000 | 2.85% |
| Soleus Capital Management, L.P. | 643,777 | $23,098,719 | 2.13% |